Pharmafile Logo

dual tasking

- PMLiVE

2Seventy bio’s partner pauses phase 1 leukaemia study following patient death

The death occurred in the first patient treated with the CAR-T cell therapy at the second dosing level

- PMLiVE

Astellas and Cullgen announce protein degrader partnership worth up to $1.9bn

The companies will use Cullgen’s protein degradation platform to discover multiple candidates

- PMLiVE

Alzheimer’s Research UK and Race Against Dementia announce £500k research pledge

The funding will allow researchers to investigate the link between air pollution and Alzheimer’s disease

- PMLiVE

VMLY&R Health appoints Natxo Diaz as global head of health craft

Diaz was most recently chief creative officer for VMLY&R Health Spain

- PMLiVE

Medscape Oncology and American Society of Clinical Oncology Collaborate to Offer Cancer-Specific Training to Multidisciplinary Members of the Oncology Care Team

This week Medscape Oncology announced an exciting collaboration with  ASCO® which you read on the Cision PR news wire here or below:The American Society of Clinical Oncology (ASCO®), a leader at...

Medscape Education

- PMLiVE

Elevating Nephrology Outcomes at #ERA23

Medscape is headed back to Milano, Italy for the 2023 European Renal Association conference, #ERA23.This year, the team is elevating the outcomes of recent nephrology education programs to share the story...

Medscape Education

- PMLiVE

To support patient-centricity in clinical trials, look to rare disease communities

How patients are seeking new treatment options that will advance the care of their communities

- PMLiVE

Ipsen’s Bylvay approved by FDA for severe itching due to Alagille syndrome

As many as 88% of patients living with the condition experience severe pruritus

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links